About Comite Mexicano Para la Prevencion de Osteoporosis AC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
R-Pharm International, LLC
2
Boehringer Ingelheim
1
Hoffmann-La Roche
1
Clinical Trials at Comite Mexicano Para la Prevencion de Osteoporosis AC
During the past decade, Comite Mexicano Para la Prevencion de Osteoporosis AC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
2011-08-02
2016-03-25
Completed
3,080
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
2016-05-24
2019-11-05
Completed
1,648
Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
2017-07-04
2021-09-01
Completed
2,106
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Comite Mexicano Para la Prevencion de Osteoporosis AC"
#1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Comite Mexicano Para la Prevencion de Osteoporosis AC
According to Clinical.Site data, the most researched conditions in "Comite Mexicano Para la Prevencion de Osteoporosis AC" are
"Rheumatoid Arthritis" (3 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Comite Mexicano Para la Prevencion de Osteoporosis AC" in a lesser frequency.
Clinical Trials Intervention Types at Comite Mexicano Para la Prevencion de Osteoporosis AC
Most popular intervention types in "Comite Mexicano Para la Prevencion de Osteoporosis AC" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Adalimumab 40mg q2w" (1 trials), "Concomitant treatment" (1 trials), "Etanercept" (1 trials), "Linagliptin" (1 trials) and "Olokizumab 64 mg SC q2w" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Comite Mexicano Para la Prevencion de Osteoporosis AC
The vast majority of trials in "Comite Mexicano Para la Prevencion de Osteoporosis AC" are
4 trials for "All" genders.
Clinical Trials Status at Comite Mexicano Para la Prevencion de Osteoporosis AC
Currently, there are NaN active trials in "Comite Mexicano Para la Prevencion de Osteoporosis AC".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Comite Mexicano Para la Prevencion de Osteoporosis AC,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Comite Mexicano Para la Prevencion de Osteoporosis AC, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".